Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men

The Effect of Testim and Training in a Population Based, Randomized, Placebo-controlled, Double-blinded Study of Hypogonadal Men

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00700024

Enrollment

Registered

2008-06-18

Start date

2008-04-30

Completion date

2010-02-28

Last updated

2009-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypogonadism, Metabolic Syndrome

Keywords

Body composition, Physical activity, Metabolic syndrome

Brief summary

The purpose of this study is to determine the effect of training and testim on Hypogonadism.

Detailed description

The effect of testim and training in hypogonadal men.

Interventions

DRUGTestim

50 mg/dose7day

BEHAVIORALStrength training

three times a week

DRUGplacebo

placebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

MALE

Age

65 Years to 78 Years

Healthy volunteers

Yes

Inclusion criteria

* Male 65-78 * Bioavailable testosterone \< 7.3 nmol/L * Waist \> 94 cm

Exclusion criteria

* Haematocrit \> 0.50 * Known c. prostate or PSA \> 3 Myg/L * Known malignant disease * Alcohol or drug abuse * BMI \> 40 kg/m2 * Use of 5 alpha reductance inhibitors * Plan to father children

Design outcomes

Primary

Measure	Time frame
Lean body mass	january 2008-january 2010

Secondary

Measure	Time frame
Insulin sensitivity, Visceral fat/liver fat, Body fat, Waist, Physical conditions and physical strengths, Adiponectin, Lipid metabolism, Subjective sensation of energy, Urine cortisol, Sexual function, Serum testosterone	january 2008-january 2010

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026